<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="grossing therapeutic agents in 2017 are biologics used to treat" exact="cancer" post="( 2, 3), diabetes ( 4), and autoimmune inflammatory"/>
 <result pre="3), diabetes ( 4), and autoimmune inflammatory disorders such as" exact="rheumatoid arthritis" post="and Crohn’s disease ( 5- 7). In each case,"/>
 <result pre="diabetes ( 4), and autoimmune inflammatory disorders such as rheumatoid" exact="arthritis" post="and Crohn’s disease ( 5- 7). In each case,"/>
 <result pre="previously to detect endosomal damage ( 31, 39, 40). Human" exact="osteosarcoma" post="(Saos-2) cells transiently expressing eGFP-hGal3 or eGFP-hGal8 were first"/>
 <result pre="et al. ( 2010) A stapled p53 helix overcomes HDMX-mediated" exact="suppression" post="of p53. Cancer Cell 18: 411– 422. OpenUrl CrossRef"/>
</results>
